PDCD1 and skin squamous cell carcinoma: Future studies examining the recurrence rates in advanced cSCC patients treated with anti-PD-1 monotherapy versus standard-of-care surgery plus or minus adjuvant radiation are necessary for correctly prognosticating and managing this population.